Nitiwarangkul Lertkong, Hongku Natthapong, Pattanaprateep Oraluck, Rattanasiri Sasivimol, Woratanarat Patarawan, Thakkinstian Ammarin
Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
Orthopaedics Surgery, Police General Hospital, Bangkok 10330, Thailand.
World J Orthop. 2024 Jan 18;15(1):73-93. doi: 10.5312/wjo.v15.i1.73.
Total hip arthroplasty is as an effective intervention to relieve pain and improve hip function. Approaches of the hip have been exhaustively explored about pros and cons. The efficacy and the complications of hip approaches remains inconclusive. This study conducted an umbrella review to systematically appraise previous meta-analysis (MAs) including conventional posterior approach (PA), and minimally invasive surgeries as the lateral approach (LA), direct anterior approach (DAA), 2-incisions method, mini-lateral approach and the newest technique direct superior approach (DSA) or supercapsular percutaneously-assisted total hip (SuperPath).
To compare the efficacy and complications of hip approaches that have been published in all MAs and randomized controlled trials (RCTs).
MAs were identified from MEDLINE and Scopus from inception until 2023. RCTs were then updated from the latest MA to September 2023. This study included studies which compared hip approaches and reported at least one outcome such as Harris Hip Score (HHS), dislocation, intra-operative fracture, wound complication, nerve injury, operative time, operative blood loss, length of hospital stay, incision length and VAS pain. Data were independently selected, extracted and assessed by two reviewers. Network MA and cluster rank and surface under the cumulative ranking curve (SUCRA) were estimated for treatment efficacy and safety.
Finally, twenty-eight MAs (40 RCTs), and 13 RCTs were retrieved. In total 47 RCTs were included for reanalysis. The results of corrected covered area showed high degree (13.80%). Among 47 RCTs, most of the studies were low risk of bias in part of random process and outcome reporting, while other domains were medium to high risk of bias. DAA significantly provided higher HHS at three months than PA [pooled unstandardized mean difference (USMD): 3.49, 95% confidence interval (CI): 0.98, 6.00 with SUCRA: 85.9], followed by DSA/SuperPath (USMD: 1.57, 95%CI: -1.55, 4.69 with SUCRA: 57.6). All approaches had indifferent dislocation and intraoperative fracture rates. SUCRA comparing early functional outcome and composite complications (dislocation, intra-operative fracture, wound complication, and nerve injury) found DAA was the best approach followed by DSA/SuperPath.
DSA/SuperPath had better earlier functional outcome than PA, but still could not overcome the result of DAA. This technique might be the other preferred option with acceptable complications.
全髋关节置换术是缓解疼痛和改善髋关节功能的有效干预措施。关于髋关节手术入路的优缺点已进行了详尽探讨。髋关节手术入路的疗效和并发症仍无定论。本研究进行了一项伞状综述,以系统评价既往的荟萃分析(MAs),包括传统后入路(PA)以及微创手术如外侧入路(LA)、直接前入路(DAA)、双切口法、迷你外侧入路和最新技术直接上方入路(DSA)或经皮辅助上囊全髋关节置换术(SuperPath)。
比较所有荟萃分析和随机对照试验(RCTs)中已发表的髋关节手术入路的疗效和并发症。
从MEDLINE和Scopus数据库建库至2023年检索荟萃分析。然后从最新的荟萃分析更新随机对照试验至2023年9月。本研究纳入比较髋关节手术入路并报告至少一项结局的研究,如Harris髋关节评分(HHS)、脱位、术中骨折、伤口并发症、神经损伤、手术时间、术中失血、住院时间、切口长度和视觉模拟评分(VAS)疼痛。数据由两名评价者独立选择、提取和评估。估计网络荟萃分析、聚类排序和累积排序曲线下面积(SUCRA)以评估治疗效果和安全性。
最终,检索到28项荟萃分析(40项随机对照试验)和13项随机对照试验。共纳入47项随机对照试验进行重新分析。校正覆盖面积结果显示高度(13.80%)。在47项随机对照试验中,大多数研究在随机过程和结局报告部分偏倚风险较低,而其他领域为中度至高度偏倚风险。直接前入路在术后3个月时HHS显著高于后入路[合并未标准化均值差(USMD):3.49,95%置信区间(CI):0.98,6.00,SUCRA:85.9],其次是直接上方入路/经皮辅助上囊全髋关节置换术(USMD:1.57,95%CI:-1.55,4.69,SUCRA:57.6)。所有入路的脱位和术中骨折发生率无差异。比较早期功能结局和复合并发症(脱位、术中骨折、伤口并发症和神经损伤)的SUCRA结果显示,直接前入路是最佳入路,其次是直接上方入路/经皮辅助上囊全髋关节置换术。
直接上方入路/经皮辅助上囊全髋关节置换术早期功能结局优于后入路,但仍无法超越直接前入路的结果。该技术可能是并发症可接受的另一种首选选择。